Treace Medical Concepts, Inc. (TMCI) has a MoatMap StockRank of 26/100 based on Quality (38/100), Value (45/100), and Momentum (31/100) factor scores. The current signal is SELL. Treace Medical Concepts is a niche medical device company focused on bunion surgery. It is a single-product story facing intensifying competition and lacks any connection to our core macro themes.
Treace Medical Concepts, Inc. is a medical device company focused on advancing the standard of care for bunion surgery through its proprietary Lapiplasty 3D Bunion Correction system. The company's competitive moat is established by its unique instrumentation, extensive clinical data supporting superior patient outcomes, and a highly specialized direct sales force. It operates as a dominant niche leader in the foot and ankle orthopedic market.
| Price | $3.47 |
| Market Cap | $200M |
| P/E (Forward) | -3.14 |
| Price/Book | 2.38 |
| Return on Equity | -66.9% |
| Return on Invested Capital | -33.6% |
| Debt/Equity | 92.76 |
| Gross Margin | 79.7% |
| Operating Margin | -36.4% |
| Revenue Growth | -10.2% |
| Free Cash Flow | $-6M |
Treace Medical Concepts, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).